Peak6 Investments LLC Natera, Inc. Call Options Transaction History

Peak6 Investments LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 11, 2022	SELL	$86.26 - $119.0 $215,650 - $297,500	-2,500 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$100.17 - $126.36 $370,629 - $467,532	-3,700 Reduced 59.68%	2,500 $279,000
Q2 2021 Aug 13, 2021	SELL	$86.05 - $119.72 $25,815 - $35,916	-300 Reduced 4.62%	6,200 $704,000
Q1 2021 May 14, 2021	SELL	$91.47 - $124.36 $1.88 Million - $2.55 Million	-20,500 Reduced 75.93%	6,500 $660,000
Q4 2020 Feb 12, 2021	SELL	$66.66 - $111.74 $419,958 - $703,962	-6,300 Reduced 18.92%	27,000 $2.69 Million
Q3 2020 Nov 13, 2020	BUY	$45.89 - $72.67 $1.41 Million - $2.24 Million	30,800 Added 1232.0%	33,300 $2.41 Million
Q2 2020 Aug 14, 2020	SELL	$26.36 - $49.86 $168,704 - $319,104	-6,400 Reduced 71.91%	2,500 $125,000
Q1 2020 May 14, 2020	BUY	$17.27 - $40.17 $63,899 - $148,629	3,700 Added 71.15%	8,900 $266,000
Q4 2019 Feb 13, 2020	BUY	$32.1 - $40.4 $166,920 - $210,080	5,200 New	5,200 $175,000
Q4 2018 Feb 13, 2019	SELL	$12.32 - $24.38 $11,088 - $21,942	-900 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$18.82 - $28.96 $16,938 - $26,064	900 New	900 $22,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.